Anhui Anke Biotechnology (Group) Balance Sheet Health
Financial Health criteria checks 6/6
Anhui Anke Biotechnology (Group) has a total shareholder equity of CN¥4.0B and total debt of CN¥5.0M, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are CN¥4.8B and CN¥894.4M respectively. Anhui Anke Biotechnology (Group)'s EBIT is CN¥915.1M making its interest coverage ratio -106.6. It has cash and short-term investments of CN¥1.2B.
Key information
0.1%
Debt to equity ratio
CN¥5.00m
Debt
| Interest coverage ratio | -106.6x |
| Cash | CN¥1.16b |
| Equity | CN¥3.95b |
| Total liabilities | CN¥894.37m |
| Total assets | CN¥4.84b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300009's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥739.8M).
Long Term Liabilities: 300009's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥154.5M).
Debt to Equity History and Analysis
Debt Level: 300009 has more cash than its total debt.
Reducing Debt: 300009's debt to equity ratio has reduced from 3.4% to 0.1% over the past 5 years.
Debt Coverage: 300009's debt is well covered by operating cash flow (16517.6%).
Interest Coverage: 300009 earns more interest than it pays, so coverage of interest payments is not a concern.